Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer

This study identified LIMK2 kinase as a disease-specific target in castration resistant prostate cancer (CRPC) pathogenesis, which is upregulated in response to androgen deprivation therapy, the current standard of treatment for prostate cancer. Surgical castration increases LIMK2 expression in mous...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Lett
Huvudupphovsmän: Nikhil, Kumar, Chang, Lei, Viccaro, Keith, Jacobsen, Max, McGuire, Callista, Satapathy, Shakti R., Tandiary, Michael, Broman, Meaghan M., Cresswell, Gregory, He, Yizhou J., Sandusky, George E., Ratliff, Timothy L., Chowdhury, Dipanjan, Shah, Kavita
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079209/
https://ncbi.nlm.nih.gov/pubmed/30716360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.01.035
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk